US Broker Ratings

Standard BioTools Inc. (LAB) Stock Analysis: Exploring a 38.67% Potential Upside Amidst Challenging Financials

Standard BioTools Inc. (NASDAQ: LAB), a healthcare company specializing in medical devices, has been drawing attention from investors due to its potential upside of 38.67%, even..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Exploring a 119% Upside Potential in Mental Health Biotech

ATAI Life Sciences N.V. (NASDAQ: ATAI) has been making significant strides in the biotechnology sector, focusing on innovative treatments for mental health disorders. As a clinical-stage..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: A Biotechnology Marvel with 92.96% Upside Potential

Investors looking to explore the burgeoning world of biotechnology may find Taysha Gene Therapies, Inc. (TSHA) an intriguing prospect. This Dallas-based clinical-stage biotechnology company is dedicated..

Talkspace, Inc. (TALK) Stock Analysis: A 77.78% Potential Upside Amidst Thriving Revenue Growth

Talkspace, Inc. (NASDAQ: TALK), a leader in virtual behavioral healthcare, is catching the eye of investors with its strong revenue growth and compelling potential for stock..

Kura Oncology, Inc. (KURA) Stock Analysis: Unveiling a 195% Potential Upside

For investors keen on the biotechnology sector, Kura Oncology, Inc. (NASDAQ: KURA) presents a compelling opportunity. As a clinical-stage biopharmaceutical company, Kura Oncology focuses on developing..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Potential Upside of Over 107% Captures Investor Attention

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a promising player in the biotechnology sector, has recently garnered significant attention from investors, primarily due to its potential upside of..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Potential 231% Upside in the Biotech Sector

Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology firm specializing in treatments for inflammatory bowel disease (IBD), is capturing investor attention with its significant upside potential. With..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 54.79% Potential Upside in the Biotech Sector

Zenas BioPharma, Inc. (ZBIO), a prominent player in the biotechnology sector, has captured the attention of investors with its potential for significant growth. The company’s strategic..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Biotechnology Innovator with 158% Upside Potential

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology firm based in San Diego, California, is making waves in the healthcare sector with its promising therapeutic developments...

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating the Ups and Downs in Cannabis Markets

Tilray Brands, Inc. (NASDAQ: TLRY) stands as a prominent player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a..

Sana Biotechnology, Inc. (SANA)

⚠️ No article content returned.

..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 180% Potential Upside in the Biotech Sector

Bicycle Therapeutics plc (NASDAQ: BCYC) is a notable player in the healthcare sector, specifically within the biotechnology industry. Headquartered in Cambridge, UK, the company is actively..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Analyzing a 173% Upside Potential Amidst Robust Revenue Growth

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is capturing investor attention with an impressive market cap of $718.54 million and a staggering potential upside of 173.06%, according to..

RxSight, Inc. (RXST) Investor Outlook: Navigating the Healthcare Innovator’s Path with Insights on Valuation and Growth Potential

RxSight, Inc. (RXST), a burgeoning name in the healthcare sector, stands at the intersection of innovation and investment potential. Specializing in the revolutionary field of light..

SIGA Technologies Inc. (SIGA) Stock Analysis: Exploring the Potential of a Healthcare Powerhouse with Robust Revenue Growth

SIGA Technologies Inc. (SIGA), a player in the healthcare sector, particularly in the drug manufacturing space, is carving out a niche with its specialized focus on..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Strong Buy Ratings and Promising Upside for Biotech Investors

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is emerging as a notable player in the biotechnology sector, focusing on innovative solutions for vision improvement. With a market capitalization..

Stoke Therapeutics, Inc. (STOK): Biotech Innovator with Strong Revenue Growth and Promising Clinical Pipeline

Investors interested in the biotechnology sector might find Stoke Therapeutics, Inc. (NASDAQ: STOK) a compelling proposition. This early-stage biopharmaceutical company is making waves in the healthcare..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 41.74% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a significant player in the healthcare staffing industry, providing essential talent management services across the United States. With..

Avanos Medical (AVNS) Stock Analysis: Navigating Challenges with a $100M Free Cash Flow

Avanos Medical, Inc. (NYSE: AVNS), a key player in the healthcare sector’s medical devices industry, presents a mixed investment narrative characterized by its innovative product offerings..

Weave Communications, Inc. (WEAV) Stock Analysis: A 84.48% Upside Potential in the Healthcare Tech Sector

In the ever-evolving landscape of healthcare technology, Weave Communications, Inc. (NASDAQ: WEAV) is making strides with its innovative solutions tailored for small to medium-sized healthcare businesses...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds